INNOVATION PLATFORM
According to the 2019 statistics of the Documentation and Information Center of the Chinese Academy of Sciences, the number of vaccine patent applications of Pulike from 2016 to 2018 ranked FOURTH in the world and second among global enterprises
Independent innovation system
The company adheres to the development concept of “innovation creates the future” and constructs two innovation platforms with high standards:
- The National Research Center for Veterinary Medicine established with the approval of the Ministry of Science and Technology and relying on Pulike.
- We have established close strategic cooperation with multiple domestic and foreign research institutions, including the Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences.
- National Research Center for Veterinary Medicine
- National recognized enterprise technology center
- National and Local Joint Engineering Laboratory for Animal Infectious Disease Diagnostic Reagents and Vaccine Development
View The Gallery
Biological safety third-level laboratory, BSL-3
The largest P3 laboratory in the southern region of the Yellow River in China
3 laboratories and supporting facilities – with a total construction area of 26000 square meters and a total project investment of 282 million yuan
View The Gallery
EXPERT TEAM
Pulike focuses on bringing in high-end talents with an international perspective, and has a high-quality R&D team with doctors and masters as the mainstay.
Deputy General Manager of Pulike Biological Engineering Inc., Director of National Research Center for Veterinary Medicine, distinguished professor of Henan Agricultural University, Doctoral Supervisor, Chief Expert of OIE Reference Laboratory of Porcine Reproductive and Respiratory Syndrome (PRRS).
Yu Xiuling
NVC Assistant Director
Assistant director of the National Veterinary Drug Engineering Technology Research Center, he received his undergraduate degree from the Department of Veterinary Medicine, Yanbian Agricultural College, his master's degree from the Department of Pathology, PLA Veterinary University, and his PhD (Veterinary Pathology) from the College of Veterinary Medicine, China Agricultural University. He has long been engaged in laboratory animal pathology testing and research work.
R&D team
Pulike has more than 270 technical R&D personnel, formed a technical R&D team with doctoral and master’s degree as the mainstay, with reasonable major structure and continuously optimizing level, it has been recognized as an excellent technical team and an advanced collective of professional.
INNOVATION ACHIEVEMENTS
According to the 2019 statistics of the Documentation and Information Center of the Chinese Academy of Sciences, the number of vaccine patent applications of Placo from 2016 to 2018 ranked fourth in the world and second among global enterprises
Innovative Technolog
Patent Application
64National certificates of new veterinary drugs
318Authorized invention patents
560 Invention patent applications
16 Scientific and technological progress awards at or above the provincial level
3China Patent Excellence Award
560Invention patent applications
17&3717 PCT, 37entered the national stage
318 Invention patents granted
35 International patents